Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …

Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is both preventable and treatable. Our understanding of the pathophysiology of this complex …

Background Long-acting beta-agonists and inhaled corticosteroids are used to treat chronic
obstructive pulmonary disease (COPD), but their effect on survival is unknown. Methods We …

Background: Treatment of moderate or severe chronic obstructive pulmonary disease
(COPD) with combinations of inhaled corticosteroids, long-acting β-agonists, and long …

The natural course of chronic obstructive pulmonary disease (COPD) is complicated by the
development of systemic consequences and co-morbidities. These may be major features in …

Rationale: Inhaled corticosteroids are commonly prescribed to patients with chronic
obstructive pulmonary disease (COPD). Objectives: To examine whether these medications …

By contrast with patients with asthma, those with chronic obstructive pulmonary disease
(COPD) are poorly responsive to the anti-inflammatory actions of corticosteroids, and these …

In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

Study objectives: We hypothesized that the BODE (body mass index, airflow obstruction,
dyspnea, and exercise capacity) index would better predict hospitalization for COPD than …

Corticosteroids are the most effective anti-inflammatory therapy for asthma and other chronic
inflammatory and immune diseases. Recently new insights have been gained into the …